A detailed history of Cim, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cim, LLC holds 16,850 shares of ABT stock, worth $1.92 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
16,850
Previous 15,710 7.26%
Holding current value
$1.92 Million
Previous $1.79 Million 1.96%
% of portfolio
0.26%
Previous 0.27%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 06, 2024

BUY
$100.73 - $112.44 $114,832 - $128,181
1,140 Added 7.26%
16,850 $1.75 Million
Q1 2024

May 20, 2024

SELL
$109.52 - $120.96 $2,299 - $2,540
-21 Reduced 0.13%
15,710 $1.79 Million
Q4 2023

Feb 23, 2024

BUY
$90.19 - $110.4 $116,886 - $143,078
1,296 Added 8.98%
15,731 $1.73 Million
Q3 2023

May 17, 2024

BUY
$95.53 - $114.62 $47,287 - $56,736
495 Added 3.27%
15,611 $1.51 Million
Q2 2023

May 17, 2024

SELL
$100.78 - $112.29 $61,979 - $69,058
-615 Reduced 3.91%
15,116 $1.65 Million
Q1 2023

May 17, 2024

SELL
$96.86 - $114.01 $41,746 - $49,138
-431 Reduced 2.74%
15,300 $1.55 Million
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $47,530 - $55,760
500 Added 3.59%
14,435 $1.59 Million
Q3 2022

Nov 02, 2022

BUY
$96.76 - $112.03 $95,405 - $110,461
986 Added 7.61%
13,935 $1.38 Million
Q2 2022

Jul 11, 2022

BUY
$102.07 - $123.37 $119,013 - $143,849
1,166 Added 9.9%
12,949 $1.42 Million
Q1 2022

Apr 12, 2022

BUY
$114.02 - $139.04 $101,021 - $123,189
886 Added 8.13%
11,783 $1.41 Million
Q4 2021

Jan 26, 2022

SELL
$115.53 - $141.46 $67,931 - $83,178
-588 Reduced 5.12%
10,897 $1.34 Million
Q3 2021

Nov 08, 2021

BUY
$116.66 - $129.06 $55,063 - $60,916
472 Added 4.29%
11,485 $1.43 Million
Q2 2021

Aug 09, 2021

BUY
$105.79 - $124.53 $178,150 - $209,708
1,684 Added 18.05%
11,013 $1.35 Million
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $30,910 - $36,417
284 Added 3.14%
9,329 $1.11 Million
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $52,290 - $56,981
498 Added 5.83%
9,045 $1.12 Million
Q3 2020

Nov 06, 2020

BUY
$91.64 - $111.29 $131,595 - $159,812
1,436 Added 20.19%
8,547 $970,000
Q2 2020

Aug 07, 2020

BUY
$76.57 - $98.0 $19,984 - $25,578
261 Added 3.81%
7,111 $650,000
Q1 2020

May 05, 2020

BUY
$62.82 - $91.86 $29,525 - $43,174
470 Added 7.37%
6,850 $541,000
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $14,916 - $16,606
190 Added 3.07%
6,380 $554,000
Q3 2019

Oct 15, 2019

BUY
$81.84 - $88.74 $55,242 - $59,899
675 Added 12.24%
6,190 $518,000
Q2 2019

Jul 22, 2019

BUY
$72.88 - $85.0 $58,668 - $68,425
805 Added 17.09%
5,515 $464,000
Q1 2019

May 06, 2019

BUY
$66.22 - $80.06 $20,197 - $24,418
305 Added 6.92%
4,710 $377,000
Q4 2018

Jan 29, 2019

SELL
$65.56 - $74.27 $983 - $1,114
-15 Reduced 0.34%
4,405 $319,000
Q3 2018

Oct 29, 2018

SELL
$60.81 - $73.36 $1,216 - $1,467
-20 Reduced 0.45%
4,420 $324,000
Q2 2018

Jul 10, 2018

SELL
$57.57 - $63.54 $132,756 - $146,523
-2,306 Reduced 34.18%
4,440 $271,000
Q1 2018

Apr 05, 2018

SELL
$56.27 - $63.62 $20,144 - $22,775
-358 Reduced 5.04%
6,746 $404,000
Q3 2017

Nov 03, 2017

SELL
$48.06 - $53.64 $961 - $1,072
-20 Reduced 0.28%
7,104 $379,000
Q2 2017

Aug 09, 2017

BUY
N/A
7,124
7,124 $346,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cim, LLC Portfolio

Follow Cim, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cim, LLC with notifications on news.